AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26799118 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical total disc replacement (TDR)
Number of subjects: 599
Study 26799118 — intervention group
Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion (ACDF)
Number of subjects: 599
Study 24631095 — intervention group
Group type: EXPERIMENTAL
Intervention: JE-CV and MMR vaccines administered concomitantly (Group 'Co-Ad')
Number of subjects: 550
Study 24631095 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR vaccine administered separately after JE-CV (Group 'MMR')
Number of subjects: 550
Study 24631095 — intervention group
Group type: EXPERIMENTAL
Intervention: JE-CV vaccine administered separately before MMR (Group 'JE-CV')
Number of subjects: 550
Study 24631095 — intervention group
Group type: COMPARATOR
Intervention: JE-CV and MMR vaccines administered separately 6 weeks apart (Groups 'JE-CV' and 'MMR')
Number of subjects: 550
Study 22691917 — intervention group
Group type: EXPERIMENTAL
Intervention: IV-administered acetaminophen 30 mg/kg, administered at the end of surgery and thereafter twice at 8-hour intervals
Number of subjects: 36
Study 22691917 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl)
Number of subjects: 36
Study 22691917 — intervention group
Group type: EXPERIMENTAL
Intervention: IV-administered acetaminophen 30 mg/kg
Number of subjects: 36
Study 19585478 — intervention group
Group type: EXPERIMENTAL
Intervention: Spearmint tea (twice a day for 30 days)
Number of subjects: 42
Study 19585478 — intervention group
Group type: COMPARATOR
Intervention: Placebo herbal tea
Number of subjects: 42
Study 17852793 — intervention group
Group type: EXPERIMENTAL
Intervention: ECC.O
Number of subjects: 40
Study 17852793 — intervention group
Group type: COMPARATOR
Intervention: Standard CPB
Number of subjects: 40
Study 15956938 — intervention group
Group type: EXPERIMENTAL
Intervention: Patching regimen recommendations from the randomized trial
Number of subjects: 90
Study 12392809 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased social support from friends
Number of subjects: 187
Study 12392809 — intervention group
Group type: COMPARATOR
Intervention: Substance-using friends or partners
Number of subjects: 187
Study 12392809 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age, lower heroin use frequency, lower cocaine use, and increased frequency of needle exchange visits
Number of subjects: 187
Study 9767554 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg daily of oral, micronized estradiol
Number of subjects: 11
Study 9767554 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 7893848 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Deprivation (SD)
Number of subjects: 11
Study 7893848 — intervention group
Group type: COMPARATOR
Intervention: Undisturbed Sleep (US)
Number of subjects: 11
Study 3148355 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate
Number of subjects: 340
Study 3148355 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 340
Study 30927124 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemospray (TC-325) with epinephrine injection
Number of subjects: 39
Study 30927124 — intervention group
Group type: COMPARATOR
Intervention: Hemoclip with epinephrine injection
Number of subjects: 39
Study 30927124 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemospray (TC-325)
Number of subjects: 39
Study 30927124 — intervention group
Group type: COMPARATOR
Intervention: Hemoclip
Number of subjects: 39
Study 29214353 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete bladder neck preservation (cBNP)
Number of subjects: 199
Study 29214353 — intervention group
Group type: COMPARATOR
Intervention: No bladder neck preservation (noBNP)
Number of subjects: 199
Study 27782887 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg
Number of subjects: 41
Study 27782887 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg
Number of subjects: 41
Study 27782887 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg
Number of subjects: 41
Study 27782887 — intervention group
Group type: COMPARATOR
Intervention: Pantoprazole 40 mg
Number of subjects: 41
Study 25238615 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk homozygotes (rs267734 variant)
Number of subjects: 100
Study 25238615 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterozygotes (rs267734 variant)
Number of subjects: 100
Study 25238615 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-risk homozygotes (rs267734 variant)
Number of subjects: 100
Study 25238615 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk allele presence
Number of subjects: 100
Study 22210362 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light therapy for 1 hour
Number of subjects: 0
Study 22210362 — intervention group
Group type: COMPARATOR
Intervention: Placebo dim red light for 1 hour
Number of subjects: 0
Study 20810251 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical Process Control (SPC) charts
Number of subjects: 38
Study 20810251 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug increase
Number of subjects: 38
Study 20810251 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug interventions identified by epileptologists
Number of subjects: 38
Study 18256392 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective HLA-B*5701 screening
Number of subjects: 1956
Study 18256392 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care approach (control group)
Number of subjects: 1956
Study 15964564 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg, n=16)
Number of subjects: 24
Study 15964564 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=8)
Number of subjects: 24
Study 12060155 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital radiography
Number of subjects: 60
Study 12060155 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiography
Number of subjects: 60
Study 10482259 — intervention group
Group type: EXPERIMENTAL
Intervention: Campath‐1H monoclonal antibody treatment
Number of subjects: 27
Study 8760782 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate, 200 micrograms once daily
Number of subjects: 427
Study 8760782 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate, 200 micrograms twice daily (400 micrograms total dose)
Number of subjects: 427
Study 8760782 — intervention group
Group type: COMPARATOR
Intervention: Placebo vehicle control
Number of subjects: 427
Study 1496505 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate rich drink
Number of subjects: 10
Study 1496505 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat rich drink
Number of subjects: 10
Study 1496505 — intervention group
Group type: COMPARATOR
Intervention: Non-calorific control drink
Number of subjects: 10
Study 6388612 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 14
Study 31384292 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative fixation (open reduction and internal fixation)
Number of subjects: 0
Study 31384292 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment (pain management, bronchodilator inhalers, oxygen support, mechanical ventilation if needed, pulmonary physical therapy)
Number of subjects: 0
Study 31384292 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative fixation
Number of subjects: 0
Study 31384292 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 0
Study 29374233 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene variants associated with longer leukocyte telomere length (LTL) in the TERT gene
Number of subjects: 9907
Study 29374233 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental hTERT-expression in primary human fibroblasts
Number of subjects: 9907
Study 25683094 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral salt supplementation (113 mmol Na(+) and 112 mmol Cl(‐))
Number of subjects: 26
Study 25683094 — intervention group
Group type: COMPARATOR
Intervention: Control group (cellulose)
Number of subjects: 26
Study 25683094 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral salt supplementation
Number of subjects: 26
Study 25683094 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26
Study 25078041 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon dioxide (CO2) insufflation
Number of subjects: 0
Study 25078041 — intervention group
Group type: COMPARATOR
Intervention: Room air insufflation
Number of subjects: 0
Study 23070151 — intervention group
Group type: EXPERIMENTAL
Intervention: IDX184 25 mg once daily for 3 days
Number of subjects: 41
Study 23070151 — intervention group
Group type: EXPERIMENTAL
Intervention: IDX184 50 mg once daily for 3 days
Number of subjects: 41
Study 23070151 — intervention group
Group type: EXPERIMENTAL
Intervention: IDX184 75 mg once daily for 3 days
Number of subjects: 41
Study 23070151 — intervention group
Group type: EXPERIMENTAL
Intervention: IDX184 100 mg once daily for 3 days
Number of subjects: 41
Study 23070151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 20518809 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 26
Study 20518809 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 26
Study 20518809 — intervention group
Group type: COMPARATOR
Intervention: Calculated LDL variability
Number of subjects: 26
Study 17961729 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (HDC) with autologous hematopoietic stem cell support (AHSCT)
Number of subjects: 0
Study 17961729 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemotherapy
Number of subjects: 0
Study 15674510 — intervention group
Group type: EXPERIMENTAL
Intervention: Landiolol 5 mg
Number of subjects: 36
Study 15674510 — intervention group
Group type: EXPERIMENTAL
Intervention: Landiolol 10 mg
Number of subjects: 36
Study 15674510 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 36
Study 12059867 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 47
Study 12059867 — intervention group
Group type: COMPARATOR
Intervention: Control (Pilocarpine only)
Number of subjects: 47
Study 9587773 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol + Carbamazepine
Number of subjects: 18
Study 9587773 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol alone
Number of subjects: 18
Study 7832389 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracoscopy
Number of subjects: 52
Study 7832389 — intervention group
Group type: COMPARATOR
Intervention: Thoracotomy
Number of subjects: 52
Study 2227553 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (3 additional courses)
Number of subjects: 41
Study 2227553 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (whole-abdomen)
Number of subjects: 41
Study 89390 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolfenamic acid
Number of subjects: 20
Study 89390 — intervention group
Group type: COMPARATOR
Intervention: Ergotamine
Number of subjects: 20
Study 89390 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid
Number of subjects: 20
Study 89390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30795782 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravascular cooling (IC)
Number of subjects: 352
Study 28087382 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg rush oral immunotherapy (ROIT) in ROIT1 group
Number of subjects: 33
Study 28087382 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg rush oral immunotherapy (ROIT) in ROIT2 group
Number of subjects: 33
Study 28087382 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events during the build-up phase
Number of subjects: 33
Study 28087382 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin prick test, specific IgE, and specific IgE/IgG4 ratio to egg fractions
Number of subjects: 33
Study 28087382 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific IgG4 levels
Number of subjects: 33
Study 28087382 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 33
Study 26043229 — intervention group
Group type: EXPERIMENTAL
Intervention: TT genotype (risk allele)
Number of subjects: 14
Study 26043229 — intervention group
Group type: COMPARATOR
Intervention: CC genotype (common allele)
Number of subjects: 14
Study 23311856 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated Skill Acquisition Program (ASAP)
Number of subjects: 360
Study 23311856 — intervention group
Group type: COMPARATOR
Intervention: Usual and Customary Therapy of Equivalent Dose (DEUCC)
Number of subjects: 360
Study 23311856 — intervention group
Group type: COMPARATOR
Intervention: Usual and Customary Therapy (UCC)
Number of subjects: 360
Study 23311856 — intervention group
Group type: COMPARATOR
Intervention: Active Monitoring Only (UCC)
Number of subjects: 360
Study 21704786 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured home-based exercise program
Number of subjects: 142
Study 21704786 — intervention group
Group type: COMPARATOR
Intervention: Supervised exercise training (SET)
Number of subjects: 142
Study 19749490 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (70 min, 2 times per week for 12 weeks)
Number of subjects: 53
Study 19749490 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise training, received exercise advice at baseline)
Number of subjects: 53
Study 19749490 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 53
Study 16473722 — intervention group
Group type: EXPERIMENTAL
Intervention: Halogen light with a 20-second curing time
Number of subjects: 90
Study 16473722 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma arc light with 2-second curing time
Number of subjects: 90
Study 16473722 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma arc light with 6-second curing time
Number of subjects: 90
Study 16473722 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma arc light with 10-second curing time
Number of subjects: 90
Study 16473722 — intervention group
Group type: COMPARATOR
Intervention: Halogen light and Plasma arc light
Number of subjects: 90
Study 15078377 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac (1 mg/kg)
Number of subjects: 57
Study 15078377 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl (2 microg/kg)
Number of subjects: 57
Study 11200732 — intervention group
Group type: EXPERIMENTAL
Intervention: Close follow‐up group (CFG)
Number of subjects: 0
Study 11200732 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone follow‐up group (TFG)
Number of subjects: 0
Study 11200732 — intervention group
Group type: EXPERIMENTAL
Intervention: Mail follow‐up group (MFG)
Number of subjects: 0
Study 11200732 — intervention group
Group type: EXPERIMENTAL
Intervention: Health diaries
Number of subjects: 0
Study 9060567 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate solution, used four times daily for 7 days starting on the first day of mouth tenderness or mouth sores.
Number of subjects: 131
Study 9060567 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution, used four times daily for 7 days starting on the first day of mouth tenderness or mouth sores.
Number of subjects: 131
Study 8326220 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior inferior turbinoplasty
Number of subjects: 80
Study 8326220 — intervention group
Group type: COMPARATOR
Intervention: No anterior inferior turbinoplasty (non-turbinectomy group)
Number of subjects: 80
Study 8326220 — intervention group
Group type: EXPERIMENTAL
Intervention: Turbinate reduction in patients with less pronounced septal deviation
Number of subjects: 80
Study 2868162 — intervention group
Group type: EXPERIMENTAL
Intervention: tamoxifen 20 mg daily
Number of subjects: 60
Study 2868162 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60
Study 31916941 — intervention group
Group type: EXPERIMENTAL
Intervention: Videolaryngoscope
Number of subjects: 45
Study 31916941 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscope
Number of subjects: 45
Study 29431126 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS treatment
Number of subjects: 66
Study 29431126 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS treatment (Control)
Number of subjects: 66
Study 26476022 — intervention group
Group type: EXPERIMENTAL
Intervention: IV tissue plasminogen activator (tPA) alone
Number of subjects: 151
Study 26476022 — intervention group
Group type: EXPERIMENTAL
Intervention: IV tPA + endovascular therapy (Solitaire stent-retriever)
Number of subjects: 151
Study 26476022 — intervention group
Group type: EXPERIMENTAL
Intervention: Union of baseline core and early follow-up Tmax > 6-second volume
Number of subjects: 151
Study 25174240 — intervention group
Group type: EXPERIMENTAL
Intervention: Spanish video explaining the risks and benefits of anesthesia
Number of subjects: 2
Study 25174240 — intervention group
Group type: COMPARATOR
Intervention: Non-video group
Number of subjects: 2
Study 22341554 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-session intervention
Number of subjects: 48
Study 22341554 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only condition (AO)
Number of subjects: 48
Study 19672742 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group II (oral compound calcium acid chelate, Vitamin AD guttate and ipriflavone)
Number of subjects: 60
Study 19672742 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group I (oral compound calcium acid chelate and Vitamin AD guttate)
Number of subjects: 60
Study 19672742 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo and compound calcium acid chelate)
Number of subjects: 60
Study 18782465 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe/simvastatin (n = 539)
Number of subjects: 768
Study 18782465 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin monotherapy (n = 229)
Number of subjects: 768
Study 16184721 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide 0.1 mg subcutaneously 3 times/day for 7 days
Number of subjects: 105
Study 16184721 — intervention group
Group type: COMPARATOR
Intervention: Control (no Octreotide)
Number of subjects: 105
Study 16184721 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 105
Study 16184721 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 105
Study 12932593 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate stenting after thrombolysis (group I)
Number of subjects: 197
Study 12932593 — intervention group
Group type: COMPARATOR
Intervention: Delayed stenting after two weeks (group II)
Number of subjects: 197
Study 10923997 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram (250 mg/day)
Number of subjects: 36
Study 10923997 — intervention group
Group type: COMPARATOR
Intervention: Control group (no disulfiram)
Number of subjects: 36
Study 8927315 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciba Vision AOSept Disinfection/Neutralization Solutions (AOSept)
Number of subjects: 84
Study 8927315 — intervention group
Group type: EXPERIMENTAL
Intervention: Opti‐Free Rinsing, Disinfection, and Storage Solution (Opti‐Free)
Number of subjects: 84
Study 8927315 — intervention group
Group type: EXPERIMENTAL
Intervention: ReNu Multi‐Purpose Solution (ReNu)
Number of subjects: 84
Study 8927315 — intervention group
Group type: EXPERIMENTAL
Intervention: CibaSoft Visitint or CibaSoft‐Standard Visitint contact lenses
Number of subjects: 84
Study 1520203 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearplan home ovulation detection kits for 3 cycles
Number of subjects: 148
Study 1520203 — intervention group
Group type: COMPARATOR
Intervention: Control group (advised about optimal time during menstrual cycle)
Number of subjects: 148
Study 6328637 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg twice daily)
Number of subjects: 339
Study 6328637 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine (1 g daily in divided doses)
Number of subjects: 339
Study 31793630 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab combination therapy (34 patients)
Number of subjects: 78
Study 31793630 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab monotherapy (44 patients)
Number of subjects: 78
Study 31793630 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab combination therapy and monotherapy
Number of subjects: 78
Study 30912010 — intervention group
Group type: EXPERIMENTAL
Intervention: RT‐HIIT
Number of subjects: 240
Study 30912010 — intervention group
Group type: EXPERIMENTAL
Intervention: AT‐HIIT
Number of subjects: 240
Study 30912010 — intervention group
Group type: COMPARATOR
Intervention: UC
Number of subjects: 240
Study 29056106 — intervention group
Group type: EXPERIMENTAL
Intervention: High dietary calcium (547 mg DC)
Number of subjects: 16
Study 29056106 — intervention group
Group type: EXPERIMENTAL
Intervention: High supplemental calcium (500 mg SC-calcium carbonate)
Number of subjects: 16
Study 29056106 — intervention group
Group type: COMPARATOR
Intervention: Low calcium (42 mg DC)
Number of subjects: 16
Study 27067867 — intervention group
Group type: EXPERIMENTAL
Intervention: Canine guided dentures
Number of subjects: 19
Study 27067867 — intervention group
Group type: COMPARATOR
Intervention: Bilateral balanced occlusion dentures
Number of subjects: 19
Study 27067867 — intervention group
Group type: EXPERIMENTAL
Intervention: New complete dentures (both occlusal concepts)
Number of subjects: 19
Study 24355490 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time explanations for noncompliance
Number of subjects: 207
Study 22607302 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based behavioral activation intervention for 8 weeks with minimal therapist contact.
Number of subjects: 120
Study 22607302 — intervention group
Group type: COMPARATOR
Intervention: Attention control group with brief online education and a smartphone application not aimed at depression for 8 weeks.
Number of subjects: 120
Study 19717844 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 110 mg twice daily
Number of subjects: 18113
Study 19717844 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg twice daily
Number of subjects: 18113
Study 19717844 — intervention group
Group type: COMPARATOR
Intervention: Warfarin (adjusted-dose)
Number of subjects: 18113
Study 17470687 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 0
Study 17470687 — intervention group
Group type: EXPERIMENTAL
Intervention: Vatalanib
Number of subjects: 0